Bakersfield Municipal Code Ch. 9.13 Unregulated Chemicals

Sections: 9.13.010 Definitions. 9.13.020 Acts prohibited. 9.13.030 Penalties. 9.13.040 Severabillty. 9.13.050 Incorporation by reference.

A. “Person” means any individual, partnership, corporation, or association of any nature whatsoever.

B. “Unregulated chemicals” means the following chemical, compound, or derivative not approved by the Federal Food and Drug Administration:

1. Adamantoylindoles or adamantoylindazoles, which includes adamantyl carboxamide indoles and
adamantyl carboxamide indazoles, or any compound structurally derived from 3-(1-adamantoyl)indole,
3-(1-adamantoyl) indazole, 3-(2-adamantoyl)indole, N-(l-adamantyl)-1H-indole-3-carboxamide, or N-
(1-adamantyl)-1H-indazole-3-carboxamide by substitution at the nitrogen atom of the indole or indazole ring
with alkyl, haloalkyl, alkenyl, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-
methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl) methyl, 1-(N-
methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in
the indole or indazole ring to any extent and whether or not substituted in the adamantyl ring to any extent,
including, but not limited to, 2NE1, SF-AKB-48, AB-001, AKB-48, AM-1248, JWH-018 adamantyl carboxamide,
STS-135.

2. Benzoylindoles, which includes any compound structurally derived from a 3-(benzoyl)indole structure
with substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-
methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl) methyl, or (tetrahydropyran-4-yl)methyl group,
whether or not further substituted in the indole ring to any extent and whether or not substituted in the
phenyl ring to any extent, including, but not limited to, AM-630, AM-661, AM-679, AM-694, AM-1241, AM-2233,
RCS-4, WIN 48,098 (Pravadoline).

3. Cyclohexylphenols, which includes any compound structurally derived from 2-(3-hydroxycyclohexyl)
phenol by substitution at the 5-position of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl,
alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N-
methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl) methyl, or (tetrahydropyran-4-yl)methyl group,
whether or not further substituted in the cyclohexyl ring to any extent, including, but not limited to, CP
47,497, CP 55,490, CP 55,940, CP 56,667, cannabicyclohexanol.

4. Cyclopropanoylindoles, which includes any compound structurally derived from
3-(cyclopropylmethanoyl) indole, 3-(cyclopropylmethanone)indole, 3-(cyclobutyl-methanone)indole or
3-(cyclopentylmethanone)indole by substitution at the nitrogen atom of the indole ring, whether or not
further substituted in the indole ring to any extent, whether or not substituted on the cyclopropyl, cyclobutyl,
or cyclopentyl rings to any extent.

5. Naphthoylindoles, which includes any compound structurally derived from 3-(1-naphthoyl)indole or 1H-
indol-3-yl-(l-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl,
cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
2-(4-morpholinyl)ethyl group, l-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or
(tetrahydropyran-4-yl)methyl group, whether or not further substituted in the naphthyl ring to any extent,
including, but not limited to, AM-678, AM-1220, AM-1221, AM-1235, AM-2201, AM-2232, EAM-2201, JWH-004,
JWH-007, JWH-009, JWH-011, JWH-015, JWH-016, JWH-018, JWH-019, JWH-020, JWH-022, JWH-046, JWH-047,
JWH-048, JWH-049, JWH-050, JWH-070, JWH-071, JWH-072, JWH-073, JWH-076, JWH-079, JWH-080, JWH-081,
JWH-082, JWH-094, JWH-096, JWH-098, JWH-116, JWH-120, JWH-122, JWH-148, JWH-149, JWH-164, JWH-166,

JWH-180, JWH-181, JWH-182, JWH-189, JWH-193, JWH-198, JWH-200, JWH-210, JWH-211, JWH-212, JWH-213,
JWH-234, JWH-235, JWH-236, JWH-239, JWH-240, JWH-241, JWH-242, JWH-258, JWH-262, JWH-386, JWH-387,
JWH-394, JWH-395, JWH-397, JWH-398, JWH-399, JWH-400, JWH-412, JWH-413, JWH-414, JWH-415, JWH-424,
MAM-2201, WIN 55,212.

6. Naphthoylnaphthalenes, which includes any compound structurally derived from naphthalene-1-yl-
(naphthalene-1-yl)methanone with substitutions on either of the naphthalene rings to any extent, including,
but not limited to, CB-13.

7. Naphthoylpyrroles, which includes any compound structurally derived from 3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N- methyl-2-pyrrolidinyl) methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahy-dropyran-4-yl)methyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including, but not limited to, JWH-030, JWH-031, JWH-145, JWH-146, JWH-147, JWH-150, JWH-156, JWH-243, JWH-244, JWH-245, JWH-246, JWH-292, JWH-293, JWH-307, JWH-308, JWH-309, JWH-346, JWH-348, JWH-363, JWH-364, JWH-365, JWH-367, JWH-368, JWH-369, JWH-370, JWH-371, JWH-373, JWH-392.

   8. Naphthylmethylindenes, which includes any compound containing a naphthylideneindene structure or which is structurally derived from 1-(1-naphthylmethyl)indene with substitution at the 3-position of the indene ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N- methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(Nmethyl -2-pyrrolidinyl)methyl, 1-(N- methyl-3-morpholinyl) methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent, including, but not limited to, JWH-171, JWH-176, JWH-220.

   9. Naphthylmethylindoles, which includes any compound structurally derived from an H-indol-3-yl- (1-naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl) ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent, including, but not limited to, JWH-175, JWH-184, JWH-185, JWH-192, JWH-194, JWH-195, JWH-196, JWH-197, JWH-199.

   10. Phenylacetylindoles, which includes any compound structurally derived from 3-phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or 1-(N- methyl-2-pyrrolidinyl) methyl, 1-(N-methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent, including, but not limited to, cannabipiperidiethanone, JWH-167, JWH-201, JWH-202, JWH-203, JWH-204, JWH-205, JWH-206, JWH-207, JWH-208, JWH-209, JWH-237, JWH-248, JWH-249, JWH-250, JWH-251, JWH-253, JWH-302, JWH-303, JWH-304, JWH-305, JWH-306, JWH-311, JWH-312, JWH-313, JWH-314, JWH-315, JWH-316, RCS-8.

   11. Quinolinylindolecarboxylates, which includes any compound structurally derived from quinolin-8-yl-1H- indole-3-carboxylate by substitution at the nitrogen atom of the indole ring with alkyl, haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N- methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl) alkyl, whether or not further substituted in the indole ring to any extent, whether or not substituted in the quinoline ring to any extent, including, but not limited to, BB-22, 5-fluoro-PB-22, PB-22.

   12. Tetramethylcyclopropanoylindoles, which includes any compound structurally derived from 3-tetra- methylcyclopropanoylindole, 3-(1-tetramethylcyclopropyl) indole, 3-(2,2,3,3-tetramethylcyclopropyl)indole or 3-(2,2,3,3-tetramethylcyclopropylcarbonyl)indole with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, cyanoalkyl, hydroxyalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N- methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 1-(N-methyl-2-pyrrolidinyl) methyl, 1-(N- methyl-3-morpholinyl)methyl, or (tetrahydropyran-4-yl)methyl group whether or not further substituted in the indole ring to any extent and whether or not substituted in the tetramethylcyclopropanoyl ring to any extent, including, but not limited to, 5-bromo-UR-144, 5-chloro-UR-144, 5-fluoro-UR-144, A-796,260, A-834,735, AB-034, UR-144, XLR11.

   13. Tetramethylcyclopropane-thiazole carboxamides, which includes any compound structurally derived from 2,2,3,3-tetramethyl-N-(thiazol-2-ylidene) cyclopropane carboxamide by substitution at the nitrogen atom of the thiazole ring by alkyl, haloalkyl, benzyl, halobenzyl, alkenyl, haloalkenyl, alkoxy, cyanoalkyl, hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)alkyl, (4-tetrahydropyran)alkyl, or 2-(4-morpholinyl)alkyl, whether or not further substituted in the thiazole ring to any extent, whether or not substituted in the tetramethylcyclopropyl ring to any extent, including, but not limited to, A-836,339.

   14. Unclassified synthetic cannabinoids, which includes all of the following:

       a. AM-087, (6aR,10aR)-3-(2-methyl-6-bromohex-2-yl)-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c] chromen-1-ol.

       b. AM-356, methanandamide, including (5Z,8Z,11Z,14Z)-N- [(1R)-2-hydroxy-1-methylethyl]icosa-5,8,11,14-tetraenamide and arachidonyl-1’-hydroxy-2’propylamide.

       c. AM-411, (6aR,10aR)-3-(1-adamantyl)-6,6,9-trimethyl-6a,7, 10,10atetrahydrobenzo[c]chromen-1-ol.

       d. AM-855, (4aR,12bR)-8-hexyl-2,5,5-trimethyl-1,4,4a,8, 9,10,11,12b- octahydronaphtho[3,2-c]isochromen-12-ol.

       e. AM-905, (6aR,9R,10aR)-3-[(E)-hept-1-enyl]-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a- hexahydrobenzo[c]chromen-1-ol. f. AM-906, (6aR,9R,10aR)-3-[(Z)-hept-1-enyl]-9-(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a-

   hexahydro-benzo[c]chromen-1-ol.

   g. AM-2389, (6aR,9R,10aR)-3-(1-hexyl-cyclobut-1-yl)6a,7,8,9,10,10ahexahydro-6,6-dimethyl-6H-dibenzo
   [b,d]pyran-1,9-diol.

   h. BAY 38-7271, (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluorobutyl-1-sulfonate.

   i. CP 50,556-1, levonantradol, including 9-hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,
   8,9,10,10a-octahydrophenanthridin-1-yl]acetate: [(6S,6aR,9R,
   10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-
   octahydrophenanthridin-1-yl]acetate: and [9-hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-5,6,6a,7,
   8,9,10,10a-octahydrophenanthridin-1-yl]acetate.

   j. HU-210, including (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-
   tetrahydrobenzo[c]chromen-1-ol;
   [(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7, 10,10a-
   tetrahydrobenzo[c]chromen-1-ol and 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol.

   k. HU-211, dexanabinol, including
   (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7, 10,10a-
   tetrahydrobenzo[c]chromen-1-ol and
   (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]
   chromen-1-ol.

   l. HU-243, 3-dimethylheptyl-11-hydroxyhexahydro cannabinol.

   m. HU-308, [(91R,2R,5R)-2-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1] hept-3-enyl]methanol.

   n. HU-331, 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclo
   hexadiene-1,4-dione.

   o. HU-336, (6aR, 10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-1Hbenzo[c]chromene-1,4(6H)-
   dione.

   p. JTE-907, N-(benzol[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-
   1,2-dihydroquinoline-3-carboxamide.

   q. JWH-051, ((6aR,10aR)-6,6-dimethyl-3-(2-methyl octan-2-yl)-6a,7,10,10a-
   tetrahydrobenzo[c]chromen-9-yl)methanol.

   r. JWH-057 (6aR,10aR)-3-(1,1-dimethylheptyl)-6a,7, 10,10a-tetrahydro-6,6,9-trimethyl-6H-
   dibenzo[b,d]pyran.

   s. JWH-133 (6aR,10aR)-3-(1,1-dimethylbutyl)-6a,7, 10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]
   pyran.

   t. JWH-359, (6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-[(2R)-1,1,2-trimethylbutyl]-6a,7, 10,10a-
   tetrahydrobenzo [c]chromene.

   u. URB-597 [3-(3-carbamoylphenyl)phenyl]-N-cyclohexylcarbamate.

   v. URB-602 [1,1’-biphenyl]-3-yl-carbamic acid, cyclohexyl ester; OR cyclohexyl-[1,1’-
   biphenyl]-3-ylcarbamate.

   w. URB-754 6-methyl-2-[(4-methylphenyl) amino]-4H-3,1-benzoxazin-4-one.

   x. URB-9373’-carbamoyl-6-hydroxy-[1,1’-biphenyl]-3-yl-cyclohexylcarbamate.

   y. WIN 55,212-2, including (R)-(+)-
   [2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-

   napthalenylmethanone and [2,3-dihydro-5-methyl-3-(4- morpholinylmethyl)pyrrolo[(1,2,3-de)-1,4-benzoxazin-6-yl]-1-napthalenylmethanone.

8. Unless specifically excepted, or contained within a pharmaceutical product approved by the United States Food and Drug Administration, any substance, including its salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers whenever the existence of such salts, isomers, esters, or ethers, and salts of isomers, esters, or ethers is-possible, that is structurally derived from 2-amino-1-phenyl-1-propanone by modification in one of the following ways:

   a. By substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide
   substituents, whether or not further substituted in the phenyl ring by one or more other univalent
   substituents.

   b. By substitution at the 3-position with an alkyl substituent.

   c. By substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen

   atom in a cyclic structure. (Ord. 4823 § 2, 2015)

A. It is unlawful for any person to use any unregulated chemical within the city of Bakersfield.

B. It is unlawful for any person to possess any unregulated chemical within the city of Bakersfield.

C. It is unlawful for any person to provide, distribute, or sell any unregulated chemical within the city of Bakersfield.

D. It is unlawful for any person to possess, with the intent to sell, any unregulated chemical within the city of Bakersfield. (Ord. 4823 § 2, 2015)

Any person who violates any provision of this chapter is subject to any and all penalties subject to Title 1 Section 1.40.010 of the Bakersfield Municipal Code, or any other manner permissible by law. (Ord. 4823 § 2, 2015)

If any section, subsection, sentence, clause or phrase of this chapter is for any reason held to be invalid or unconstitutional, the decision shall not affect the validity of the remaining portions of the chapter. The city council hereby declares that it would have passed the ordinance codified in this chapter, and each section, subsection, sentence, clause, and phrase thereof, irrespective of the fact that any one or more sections, subsections, sentences, clauses, or phrases be declared invalid under law. (Ord. 4823 § 2, 2015)

Section 9.44.090 of the Kern County Ordinance Code concerning psychoactive bath salts, psychoactive herbal incense and other synthetic drugs and all subsequent amendments or revisions thereto is hereby incorporated by this reference as if fully set forth herein verbatim. (Ord. 4895 § 1, 2017)